← Back to Calendar
Live Company Data
NGM
Updated
just now
· Data: FMP
Current Price
$84.39
+45.93%
+$26.56 today
Day: $82.96 – $86.19
Market Cap
N/A
Shares out: 68.29M
Float: 55.45M
52-Week Range
Current price is at 43% of 52-week range
Sector
Healthcare
Biotechnology
⚠️ Financial data is for informational purposes only. Not investment advice. Prices may be delayed.
Indication
Q1 2026 earnings + acquired HO commercial launch update
Key Notes
Q1 2026 earnings expected ~May 2026. IMCIVREE acquired HO PDUFA March 20, 2026 — if approved, Q1 earnings will include early launch data. EMA CHMP opinion expected Q2 2026. EMANATE Phase 3 topline data expected early 2026.
⚠️ Not Investment Advice: This information is provided for educational purposes only.
PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period,
issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on
historical base rates and do not account for drug-specific factors. Always consult a financial advisor
before making investment decisions.
Discussion
Share your analysis, research, or questions about this catalyst. No account required.